Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 37Myelodysplastic Syndromes 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Leukemia 11Hematologic Neoplasms 10Lymphoma 9Hodgkin Disease 9Anemia, Refractory, with Excess of Blasts 9Myeloproliferative Disorders 8Multiple Myeloma 8Lymphoma, Non-Hodgkin 8Leukemia, Myelomonocytic, Chronic 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia, Biphenotypic, Acute 7Graft vs Host Disease 7Leukemia, Lymphocytic, Chronic, B-Cell 6Primary Myelofibrosis 5Neuroblastoma 4Myelodysplastic-Myeloproliferative Diseases 4Leukemia, Myeloid 4Congenital Abnormalities 4Anemia, Aplastic 4Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precancerous Conditions 3Polycythemia Vera 3Lymphoproliferative Disorders 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3

Interventions

Azacitidine 2aldesleukin 1Whole-Body Irradiation 1Vorinostat 1Peripheral Blood Stem Cell Transplantation 1Idarubicin 1Gemtuzumab 1Filgrastim 1Etoposide 1Cytarabine 1Busulfan 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Erythroblastic, Acute × Busulfan × 1 year × Clear all
NCT00534469 2025-12-02

Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R

City of Hope Medical Center

Phase 2 Completed
60 enrolled 9 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡